[1]
D. Ivanov, O. Kuryata, and I. Garmysh, “Renin angiotensin-aldosterone system blockers: chronic kidney disease and cardiovascular risk”, KIDNEYS, vol. 7, no. 2, pp. 81–90, Sep. 2021.